The ICTR laboratories provide coordinated help across several related programs, all focused on the foundational components required to effectively translate new drugs, biologics, vaccines, devices, biomarkers and diagnostics into clinical trials and eventually clinical practice.
Biologics Translational Program
Offers biologic product development and testing Consultative support for biologic development Preclinical testing to clinical production.
Cardiovascular Imaging Laboratory
Provides echocardiographic and carotid imaging for approved CRU protocols, as well as measurement of endothelial function and arterial stiffness.
Clinical Research Unit Core Laboratory
Offers 87 distinct assays of clinical chemical endpoints and biomarkers to support ICTR research protocols and is designed to serve investigators at all clinical research unit locations.
Imaging Translational Program
Facilitates one-on-one consultation with imaging experts for study design, imaging protocol development and study implementation.
Genetics Translational Technology Program
Bridges the gap between clinical genetic testing and research-driven molecular technologies with consulting and laboratory services and assistance with translation of molecular technologies to the clinical environment.
Drug Screening, Development & Analysis Units
Maintains, distributes, and screens drug library (FDA approved) compounds. This unit is ideal for re-purposing licensed drugs by screening activity against new targets.
Proteomic Biomarker Development Program
Couples mass spectrometry to one and two dimensional separations by column chromatography or gel electrophoresis to identify, quantify or characterize proteins.
Provides consultation to basic, clinical, and translational research teams regarding the feasibility, design, and costs of projects using metabolomics technologies.
Medicinal Chemistry Unit
Synthesizes small molecule when it is not commercially available and supports structure-activity relationship studies.